Who
Anna Nijdam
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Pharvaris.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $615K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2026
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $82K2,670 at $30.87 | filing |
| 4 Jun 2026filed 8 Jun 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $82K2,670 at $30.87 | filing |
| 22 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $110K5,501 at $20.00 | filing |
| 22 May 2026filed 26 May 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,501 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $169K5,501 at $30.74 | filing |
| 22 May 2026filed 26 May 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,501 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $110K5,501 at $20.00 | filing |
| 22 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $169K5,501 at $30.74 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $37K1,829 at $20.00 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $56K1,829 at $30.60 | filing |
| 21 May 2026filed 26 May 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,829 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,829 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $37K1,829 at $20.00 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $56K1,829 at $30.60 | filing |
| 11 Apr 2026filed 14 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $15K548 at $26.63 | filing |
| 11 Apr 2026filed 14 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $15K548 at $26.63 | filing |
| 6 Apr 2026filed 8 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $33K1,167 at $28.56 | filing |
| 6 Apr 2026filed 8 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $33K1,167 at $28.56 | filing |
| 1 Apr 2026filed 3 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $33K1,164 at $28.25 | filing |
| 1 Apr 2026filed 3 Apr 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code F | $33K1,164 at $28.25 | filing |
News
No headline names them, or the companies they trade most, lately.